Whose Acute Low Back Pain will Become Chronic?
A new study on conversion of acute to chronic low back pain identifies clinician behavior as well as patient characteristics that increase that risk.
Pfizer-BioNTech COVID Vaccine Efficacy High at 6 Months, Companies Report
The COVID-19 vaccine partners announced an efficacy rate of >90% for BNT162b2 among 12 000 trial participants at up to 6 months after the second dose.
Dapagliflozin Found Effective for HFrEF in Men and Women
In a subanalysis of the landmark DAPA-HF trial, dapagliflozin benefits were observed in both men and women, an important finding given variable response to cardiovascular drugs among women.
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of March 31, 2021
Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.
6 New Drugs Approved for Primary Care: Q1 2021
The end of another quarter means a new list of FDA-approved drugs for primary care. Which ones should you know about?
Pfizer-BioNTech COVID-19 Vaccine Found 100% Effective in Younger Teens
Pfizer-BioNTech announced today the complete protection against infection with SARS-CoV-2 among youth aged 12 to 15 years.
SARS-CoV-2 Variants: How Many and How Dangerous?
The CDC defines 3 classes of SARS-CoV-2 variants: Variants of interest, of concern, and of high consequence. Find out more about the 8 variants now being closely observed.
COVID-19 Updates: US and Global Cases, Deaths, and Vaccinations as of March 30, 2021
In Adults with NAFLD and Severe Obesity, Bariatric Surgery Significantly Reduces Cancer Risk
Study authors looked for the first time at the impact of bariatric surgery on incidence of all-cause and obesity-related cancer in patients with severe obesity and fatty liver disease.
COVID-19: Bamlanivimab-Etesevimab Antibody Cocktail Reduces Risk of Hospitalization, Death
New data suggests that the antibody cocktail, bamlanivimab plus etesevimab, reduces the risk of COVID-19-related hospitalizations and death by 87% in high-risk COVID-19 patients.
COVID-19 Vaccination Stats: Frontline Health Care Workers
Survey: Slightly more than one-half of US frontline healthcare workers have received at least 1 dose of a COVID-19 vaccine. But some still plan not to get vaccinated at all.
COVID-19 Updates: US and Global Cases, Deaths, and Recoveries as of March 29, 2021
Flu Vaccine Shown to Reduce Mortality, CV Events in Adults with CVD
Influenza vaccination is associated with lower risk for all-cause and cardiovascular death in patients with CVD vs no vaccination, a new meta-analysis found.
COVID-19 Updates: US and Global Cases, Deaths, and Recoveries as of March 26, 2021
US confirmed cases of COVID-19 have surpassed 30 million; global cases have reached 125 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
CDC Guidance for Fully Vaccinated Persons: Part 2
In part 2 of our series on the CDC guidance, find questions you may be asked by patients about quarantine and testing, and the answers to help prepare.
Survey: Americans are Emerging, Vaccinated or Not
COVID-19 vaccination numbers are climbing and US adults feel better about eating out, visiting friends, etc. A new survey suggests it may not be vaccinated individuals leading the way.
New Consensus Document Highlights Which Exercises are Best to Lower Blood Pressure
The new consensus document is the first to offer personalized advice on the most effective exercises to lower blood pressure based on a patient's current blood pressure level.
Flu Shot May Protect Against COVID-19, Reduce Severity, Study Finds
Individuals vaccinated against influenza were 24% less likely to be infected with COVID-19 than those who did not get the flu shot, according to Michigan Medicine researchers.
COVID-19 Updates: US and Global Cases, Deaths, and Recoveries as of March 25, 2021
Asthma of Obesity: Investigator Explains the Phenotypes
Asthma of obesity affects more than 10% of men and 14% of women with obesity. Our interview with researcher Anne Dixon, MD, sheds light on this poorly appreciated asthma phenotype.